Consuming One Avocado Per Day Reduces Circulating Oxidized LDL
For adults with overweight and obesity, a heart-healthy diet that includes 1 avocado per day can decrease circulating oxidized low-density lipoprotein concentrations.
Dyslipidemia
Borderline Personality Disorder May Increase Cardiometabolic Risk
The researchers found that both BPD features and depressive symptomatology were both related to the extent of cardiometabolic risk.
How Should High Lipoprotein(a) Levels Be Addressed?
To summarize key strategies for Lp(a) management, HEART UK published a consensus statement outlining recommendations for Lp(a) measurement and treatment in patients with elevated concentrations.
Residual Hypertriglyceridemia With Statin Treatment Common in Diabetes
One-third of patients with diabetes and HTG overall and approximately 40% of statin users were found to be at high long-term cardiovascular risk.
Hidradenitis Suppurativa Carries Heavy Comorbidity Burden
There is a substantial burden, unawareness, and undertreatment of several systemic comorbidities—particularly cardiovascular and psychiatric—in patients with HS.
More Aggressive Therapy Needed for Many Patients With Familial Hypercholesterolemia
Even with care in specialty clinics, LDL-C persists above target levels in more than half of patients with familial hypercholesterolemia.
Elevated Triglycerides Linked to Worse CV and Health Economic Outcomes
Researchers used using observational administrative claims data from the Optum Research Database to retrospectively examine the real-world effect of elevated triglyceride levels on cardiovascular outcomes and medical cost.
Polypill Regimen Reduces Blood Pressure, LDL-C in Underserved Patients
Compared with usual care, a polypill regimen led to greater reductions in systolic blood pressure and low-density lipoprotein cholesterol level in socioeconomically vulnerable minority patients.
Studies Show Inclisiran Benefits Patients With HeFH, ASCVD, and Elevated LDL-C
Full detailed data will be presented at the AHA Scientific Sessions in Philadelphia in November 2019.
Atherosclerosis Associated With Increased Disease Duration, T2D in Rheumatoid Arthritis
Investigators examined both incidence and predictive factors of subclinical and clinical atherosclerosis in patients with rheumatoid arthritis.
Next post in Type 2 Diabetes
